Patient Square Capital’s Inventiva IVA Stock Holding History

Patient Square Capital’s Portfolio IVA Stock Details IVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.44M	Buy	+1,967,171	New	+$9.45M	1.15%	21

Other funds holding IVA

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Andera Partners Paris $206M AUM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Millennium Management

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Franklin Resources

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Squadron Capital Management Westmont, Illinois $322M AUM

Patient Square Capital's IVA Position: Q2 2026 in Review

Patient Square Capital opened a new position in Inventiva (IVA) in Q2 2026: 1,967,171 shares worth $7.44M. The stake represents 1.15% of the portfolio and ranks #21 among its holdings.

88 funds tracked by Wall St. Rank hold IVA as of Q2 2026.

Patient Square Capital held 1,967,171 shares of Inventiva worth $7.44M as of Q2 2026.
Inventiva was a new Patient Square Capital position in Q2 2026.
Inventiva made up 1.15% of Patient Square Capital's portfolio in Q2 2026, its #21 holding.
88 funds tracked by Wall St. Rank held Inventiva as of Q2 2026.

Based on Patient Square Capital's 13F filing for Q2 2026, filed 12 Aug 2026.